Ovarian cancer has the highest mortality rate of all gynecologic cancers as 62% of cases are diagnosed at an advanced stage. The main concern in the surgical management of ovarian cancer is to achieve optimal cytoreductive surgery. Effective cytoreductive surgery at the time of initial therapy has been identified as the most important prognostic factor in the management of advanced ovarian cancer. This aggressive approach can cause unusual surgical management modalities including diaphragm stripping/resection, bowel resection, hepatic resection and splenectomy. Thus, splenectomy occasionally happens to be part of the ovarian cancer surgery.
INTRODUCTION
Splenectomy with or without distal pancreatectomy is part of cytoreductive surgery, which is used in the treatment of advanced and recurrent ovarian cancer in order to achieve complete cytoreduction.
The indications for splenectomy are: a) direct involvement of metastatic omentum (omental cake) or peritoneal metastasis (in left hemidiaphragm) -in more than 80% of the cases with advanced cancer or recurrent ovarian cancer b) solitary or parenchymal splenic metastases (rarely) c) Iatrogenic injury of the spleen during mobilization of the surrounding tissues.
The spleen is involved by metastases in part of the omentum after incomplete omentectomy (infracolic) (1). Manci (2006) reported 24 patients with involvement of the spleen: the hilum was affected in 12 and 12 had metastases on the surface or parenchyma (1). Splenectomy did not lead to the increase of early postoperative morbidity and according to the authors this procedure is safe as part of cyto-
SURGICAL TECHNIQUE
There are two main steps when performing splenectomy:
1. The mobilization of the spleno-pancreatic complex. It consists of liberation (ligation and transaction) of the gastrocolic and gastrolienal ligament, which are part of the great omentum and the splenocolic and phrenocolic ligament, as well. Mobilization and supracolic omentectomy are performed simultaneously ( Fig. 4 ). 2. Separating the spleen from the pancreatic tail or its transection (distal pancreatectomy) and ligation of lienal artery and vein. Two approaches are used: ventral (the separation is performed from the visceral surface of the spleen) and dorsal -from its parietal surface ( Fig. 5 , Fig. 6 ).
During the ventral approach there is a risk of damage of the pancreas and conditions for postoperative pancreatic fistula and this approach should be performed only in cases with hilar pancreatic metastases which involve the pancreatic tail and require distal pancreatectomy with splenectomy.
In all other conditions without involvement of the pancreatic tail, the dorsal approach should be performed because it is safe and prevents pancreatic fistulas. The dorsal approach has an anatomic bloodless approach between the tail of pancreas and the lienal artery and vein ( Fig. 7, Fig. 8 ).
After the presenting the lienal vessels they are clamped and the spleen is removed with the metastases. reductive surgery. Otrock (2006) reported 17 cases with solitary metastases in the spleen which occurred between 2 and 10 years after the primary treatment, mostly hematogenously (2) . According to Farrias E (1993) solitary spleen metastases were diagnosed by CA-125 elevation and PET/CT. Furukawa (2007) reported excellent survival in cases of solitary metastases when surgery and subsequent chemotherapy (CT) (Platinum) were applied (3, 4) . Intraoperative splenic injures are the third reason, mainly in emergency splenectomy. They usually occur after pulling anatomical structures (mostly omentum or flexura lienalis of colon transversum), which form dense adhesions with the spleen. Fig. 1, 2 and 3 demonstrate the main indications for splenectomy. The clamping is carried out at distance of the hilum of the spleen where there are many lienal branches that may cause unnecessary bleeding. Patients' outcome -1 patient died after mesenteric thrombosis, 1-patients with chylous ascites after distal pancreatectomy, other patients were alive until June 2016. Eisenkop SM, (2006) compares 47 cases with splenectomy and 307 cases without splenectomy at the time of primary cytoreductive surgery.
PATIENTS' CHARACTERISTICS

DISCUSSION
Splenectomy was associated with more advanced stage and more extensive surgery. According to the author splenectomy leads to better survival rate when a complete cytoreduction was achieved; does not increase postoperative complications and it is associated with longer operative time. The procedure does not change blood loss and hospital stay (4). Magtibay (2006) reported 66 cases of splenectomy during primary cytoreduction without complications (5) .
The resection of a part of the pancreatic tail with splenectomy increases the risk of complications, mostly pancreatic fistulas. Yildirim Y. (2005) performed resection of the tail of the pancreas in patients with pancreatic metastases in 6% of the cases with advanced ovarian cancer, and the procedure led to complete cytoreduction and acceptable morbidity (6) .
Kehoe SM (2009) presented 17 cases with distal pancreatectomy and the rate of complication was 24% (pancreatic leakage) (7).
